Biohaven Pharmaceuticals
215 Church Street
• New Haven, CT 06510
US
Biohaven is a clinical-stage biopharmaceutical company with proven leadership in industry and academic settings. Our portfolio is comprised of innovative, late-stage product candidates targeting neurological and neuropsychiatric diseases, including rare disorders. Our progress is fueled by an entrepreneurial organizational structure and an impressive range of experience in drug development along with the confident support of top-tier biopharma investors.
Categories
1 WalletHub, 2022; 2 WalletHub, 2023; 3 WalletHub, 2022; 4 U.S. Census Bureau, ACS 1Y, 2021; 5 Defined as per capita GDP, U.S. Bureau of Economic Analysis, 2022;
